Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Conductive hydrogel-based materials are attracting considerable interest for bioelectronic applications due to their ability to act as more compatible soft interfaces between biological and electrical systems. Despite significant advances that are being achieved in the manufacture of hydrogels, precise control over the topographies and architectures remains challenging. In this work, we present for the first time a strategy to manufacture structures with resolutions in the micro-/nanoscale based on hydrogels with enhanced electrical properties. Gelatine methacrylate (GelMa)-based inks were formulated for two-photon polymerisation (2PP). The electrical properties of this material were improved, compared to pristine GelMa, by dispersion of multi-walled carbon nanotubes (MWCNTs) acting as conductive nanofillers, which was confirmed by electrochemical impedance spectroscopy and cyclic voltammetry. This material was also confirmed to support human induced pluripotent stem cell-derived cardiomyocyte (hPSC-CMs) viability and growth. Ultra-thin film structures of 10 µm thickness and scaffolds were manufactured by 2PP, demonstrating the potential of this method in areas spanning tissue engineering and bioelectronics. Though further developments in the instrumentation are required to manufacture more complex structures, this work presents an innovative approach to the manufacture of conductive hydrogels in extremely low resolution.

Details

Title
Development of Conductive Gelatine-Methacrylate Inks for Two-Photon Polymerisation
Author
Sanjuan-Alberte, Paola 1   VIAFID ORCID Logo  ; Jayasheelan Vaithilingam 2 ; Moore, Jonathan C 3   VIAFID ORCID Logo  ; Wildman, Ricky D 2 ; Tuck, Christopher J 2 ; Alexander, Morgan R 4 ; Hague, Richard J M 2 ; Rawson, Frankie J 5   VIAFID ORCID Logo 

 Regenerative Medicine and Cellular Therapies, Biodiscovery Institute, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK; Department of Bioengineering and Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal 
 Centre for Additive Manufacturing, Faculty of Engineering, University of Nottingham, University Park, Nottingham NG7 2RD, UK; [email protected] (J.V.); [email protected] (R.D.W.); [email protected] (C.J.T.); [email protected] (R.J.M.H.) 
 School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, UK; [email protected] 
 Advanced Materials and Healthcare Technologies, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK; [email protected] 
 Regenerative Medicine and Cellular Therapies, Biodiscovery Institute, School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK 
First page
1038
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
20734360
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2550250485
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.